A study of academic emergency departments showed that fewer than 1% of opioid-naïve patients given IV opioids for acute pain developed persistent opioid use.
The trial will assess EMP-01's safety, tolerability and efficacy, addressing an unmet need as no new treatments for SAD have been approved in over 20 years. IBX-210: IV Ibogaine for Opioid Use ...
In 2023, more than 80,000 people in the United States died of opioid overdoses. An overdose occurs when a person takes too much of an opioid (morphine, heroin, fentanyl, etc.) or a combination of ...
The short duration of activity of naloxone when the drug is administered as an i.v. bolus may limit its effectiveness for the management of OIP. Intravenous access may not be feasible for all ...
Good afternoon and welcome to the Sangamo Therapeutics Third Quarter 2024 Teleconference Call. Please be advised that today's conference is being recorded. I would now like to turn the conference over ...